Secretory phospholipase A2-IIa is involved in prostate cancer progression and may potentially serve as a biomarker for prostate cancer
2010 · Carcinogenesis · 92 citations
https://doi.org/10.1093/carcin/bgq188
K
Kieran F. Scott
Ingham Institute(AU)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
127
Papers
4.6K
Citations
34
h-index
73
i10-index
Kieran F. Scott is an academic researcher from Ingham Institute. The author has contributed to research in topics: Legume Nitrogen Fixing Symbiosis & Protein Kinase Regulation and GTPase Signaling & Inflammatory mediators and NSAID effects. The author has an h-index of 34, co-authored 108 publications.
ORCID: 0000-0002-6012-4107Papers by this author
worksHuman TERT promoter mutations as a prognostic biomarker in glioma
2021 · Journal of Cancer Research and Clinical Oncology · 71 citations
https://doi.org/10.1007/s00432-021-03536-3
Secreted phospholipase A <sub>2</sub> enzymes as therapeutic targets
2003 · Expert Opinion on Therapeutic Targets · 29 citations
https://doi.org/10.1517/14728222.7.3.427
Selective Inhibition of Human Group IIA-secreted Phospholipase A2 (hGIIA) Signaling Reveals Arachidonic Acid Metabolism Is Associated with Colocalization of hGIIA to Vimentin in Rheumatoid Synoviocytes
2013 · Journal of Biological Chemistry · 27 citations
https://doi.org/10.1074/jbc.m112.397893
Chondroitin Sulfate Proteoglycan 4 as a Marker for Aggressive Squamous Cell Carcinoma
2022 · Cancers · 14 citations
https://doi.org/10.3390/cancers14225564
Choice of antibody is critical for specific and sensitive detection of androgen receptor splice variant-7 in circulating tumor cells
2022 · Scientific Reports · 3 citations
https://doi.org/10.1038/s41598-022-20079-w
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat